We are live on
!
Find out more
TCM
Towercrest Capital Management Portfolio holdings
AUM
$642M
1-Year Est. Return
11.71%
This Fund
S&P 500
This Quarter
Est. Return
-11.1%
1 Year Est. Return
+11.71%
3 Year Est. Return
+31.42%
5 Year Est. Return
+23.73%
10 Year Est. Return
+78.8%
AUM
$447M
AUM Growth
-$65.8M
(-13%)
Cap. Flow
-$7.08M
Cap. Flow
% of AUM
-1.58%
Top 10 Holdings %
Top 10 Hldgs %
46.44%
Holding
94
New
3
Increased
32
Reduced
29
Closed
3
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Floating Rate Bond ETF
FLOT
|
+$1.04M |
| 2 |
Schwab US Dividend Equity ETF
SCHD
|
+$667K |
| 3 |
State Street SPDR Bloomberg Investment Grade Floating Rate ETF
FLRN
|
+$666K |
| 4 |
Invesco Emerging Markets Sovereign Debt ETF
PCY
|
+$651K |
| 5 |
iShares Core Dividend Growth ETF
DGRO
|
+$581K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Schwab US Aggregate Bond ETF
SCHZ
|
+$3.82M |
| 2 |
iShares Core US Aggregate Bond ETF
AGG
|
+$2.93M |
| 3 |
PHAS
PhaseBio Pharmaceuticals, Inc. Common Stock
PHAS
|
+$1.39M |
| 4 |
Schwab US Large- Cap ETF
SCHX
|
+$1.25M |
| 5 |
IFLN
Invesco Bloomberg Enhanced Fallen Angels ETF
IFLN
|
+$723K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 2.69% |
| 2 | Communication Services | 0.75% |
| 3 | Healthcare | 0.63% |
| 4 | Financials | 0.44% |
| 5 | Consumer Staples | 0.38% |
Similar funds
APC
RR
GECH
WHGAM
PCM
CRCM
SFG
SCP
Towercrest Capital Management's Q2 2022 Portfolio in Review
As of Q2 2022, Towercrest Capital Management held 94 positions worth $447M, down 13% from $513M the previous quarter. Its ten largest holdings account for 46% of the portfolio.
Towercrest Capital Management's Q2 2022 filing shows 3 new, 32 increased, 29 reduced and 3 closed positions. Its largest new stake was Precision BioSciences: 5,156 shares worth $248K. The largest sale was Schwab US Aggregate Bond ETF, an estimated $3.82M.
By sector, the portfolio is most concentrated in Technology at 2.7% of assets, down from 2.9% a quarter earlier, followed by Communication Services and Healthcare.
- Towercrest Capital Management's largest Q2 2022 buy was Precision BioSciences: 5,156 shares worth $248K.
- Towercrest Capital Management added most to iShares Floating Rate Bond ETF in Q2 2022, an estimated $1.04M increase.
- Towercrest Capital Management's biggest Q2 2022 reduction was Schwab US Aggregate Bond ETF, cutting an estimated $3.82M.
- Towercrest Capital Management fully exited PhaseBio Pharmaceuticals, Inc. Common Stock in Q2 2022, selling an estimated $1.39M.
- Towercrest Capital Management's ten largest holdings make up 46% of its $447M portfolio in Q2 2022.
- Towercrest Capital Management opened 3 new positions and closed 3 in Q2 2022.
- Towercrest Capital Management's portfolio value fell 13% quarter-over-quarter to $447M.
Based on Towercrest Capital Management's 13F filing for Q2 2022, filed 11 Aug 2022.